New patents
Sr no
|
Patent number
|
name
|
company
|
INDICATION
|
REMARKS, WAIT FOR STR TO APPEAR
|
1
|
US-20170349608
|
RIFAXIMIN
|
ZYDUS CADILA
|
Diarrhea; Diverticulosis; Escherichia coli infection; Hepatic encephalopathy; Hyperammonemia; Intestine infection; Irritable bowel syndrome
| |
2
|
WO-2017210261
|
FEVIPIPRANT
|
CONCERT
|
Allergic rhinitis; Asthma; Atopic dermatitis
| |
3
|
WO-2017208258
|
GADOXETATE
|
BIOPHORE
|
Liver tumor
| |
4
|
WO-2017208253
|
IVACAFTOR
|
CSIR
|
Cystic fibrosis
| |
5
|
WO-2017208251
|
BREXPIPRAZOLE
|
CIPLA
|
Major depressive disorder; Schizophrenia
| |
6
|
WO-2017208169
|
BETRIXABAN
|
REDDYS
| Thromboembolism | |
7
|
WO-2017208165
|
OBETICHOLIC ACID
|
REDDYS
|
Primary biliary cirrhosis
| |
8
|
WO-2017208156
|
ELUXADOLINE
|
SUN
|
Diarrhea predominant irritable bowel syndrome
| |
9
|
WO-2017208132
|
GALETERONE
|
INDUSTRIALE
| Prostate tumor | |
10
|
WO-2017208105
|
DOLUTEGRAVIR
|
LUPIN
|
HIV infection
| |
11
| WO-2017207648 |
OBETICHOLIC ACID
|
BIONICE
|
Primary biliary cirrhosis
| |
12
|
WO-2017206808
|
DAPAGLIFLOZIN
|
CHINA SIP
|
Non-insulin dependent diabetes
| |
13
|
WO-2017206689
|
LINAGLIPTIN
|
SHENZEN
|
Non-insulin dependent diabetes
| |
14
|
WO-2017206688
|
OMBITASVIR
|
SHENZEN
|
Hepatitis C virus infection
| |
No comments:
Post a Comment